ONVO Insider Trading Activity and SEC Form 4 Filings
ONVO insider trading summary
No open-market insider purchases or sales of Organovo Holdings, Inc. (ONVO) have been reported on SEC Form 4 in the past 12 months.
Latest ONVO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 15, 2023 | David Gobel | Insider | Sell | $32K (19,607 @ $1.62) |
| Aug 17, 2021 | Douglas Jay Cohen | Director | Buy | $59K (8,750 @ $6.72) |
| Aug 17, 2021 | Douglas Jay Cohen | Director | Buy | $7K (1,000 @ $6.72) |
| Aug 17, 2021 | Douglas Jay Cohen | Director | Buy | $7K (1,000 @ $6.74) |
| Aug 16, 2019 | Steven George Hughes | Chief Medical Officer | Sell | $6K (22,230 @ $0.29) |
| Nov 8, 2018 | Sharon Collins Presnell | Chief Scientific Officer | Sell | $51K (40,000 @ $1.27) |
| Nov 24, 2017 | Keith Murphy | Insider | Buy | $299K (200,500 @ $1.49) |
| Nov 22, 2017 | Keith Murphy | Insider | Buy | $202K (135,000 @ $1.50) |
| Feb 9, 2017 | Keith Murphy | Chairman, CEO and President | Sell | $92K (25,000 @ $3.68) |
| Jan 24, 2017 | Keith Murphy | Chairman, CEO and President | Sell | $70K (20,100 @ $3.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.